Stimcell Energetics (STME) EBITDA Margin Growth (1y) (2017 - 2023)
Stimcell Energetics (STME) EBITDA Margin Growth (1y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 146.00 |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | -7.45 Mn |
| Feb 28, 2023 | -2.10 Mn |
| Nov 30, 2022 | -605,663.00 |
| Aug 31, 2022 | -851,826.00 |
| May 31, 2022 | 41,292.00 |
| Feb 28, 2022 | -1.86 Mn |
| Nov 30, 2021 | -50,717.00 |
| Aug 31, 2021 | -630,749.00 |
| May 31, 2021 | -1.31 Mn |
| Feb 28, 2021 | 254,179.00 |
| Nov 30, 2020 | -677,073.00 |
| Aug 31, 2020 | -1.21 Mn |
| Feb 28, 2017 | -4.59 Mn |